A 78-year-old client with creatinine clearance of 39 mL/min and chronic divalproex therapy had a meropenem 1 g every-8-hours order held before the first dose. After prescriber, pharmacist, and neurology review, meropenem 1 g every 12 hours and a seizure-protection plan were documented because no equally appropriate alternative was available. Review the treatment trend and select the best outcome interpretation and ongoing plan.
Trend
Choose your responses, then check the answer.
Explanation
The revised every-12-hour regimen matches the 26-to-50 mL/min renal band, renal function and neurologic status remain stable, and seizure control is preserved under the documented monitoring plan.
Quick answer The plan is currently effective and safer: continue the verified renal interval and ongoing renal, neurologic, and seizure-control surveillance.
Why this is correct A creatinine clearance of 39 to 44 mL/min remains in the labeled every-12-hour band. Stable orientation, absence of myoclonus or seizures, improving infection findings, and a stable alternative antiseizure plan support the outcome without eliminating the need for monitoring.
Easy analogy or mental picture A corrected route with steady dashboard readings is progress, but the dashboard stays on for the full trip.
Memory hook Right interval plus stable kidney, brain, and infection trend means continue and watch.
NCLEX decision rule Evaluate both therapeutic response and toxicity prevention. A single normal value does not replace serial organ-function and neurologic assessment.
Why the other choices are wrong Returning to every 8 hours ignores the current clearance; stopping all therapy ignores the improving but still active infection.
References
1DailyMed: Meropenem for InjectionCockcroft-Gault renal schedule, seizure potential, and valproate interaction
2Valproate Interaction With Carbapenems: Review and RecommendationsPeer-reviewed synthesis of subtherapeutic valproate and breakthrough seizure risk
Post-clarification renal and neurologic trendEvaluate infection response without mistaking early stability for permission to stop renal, neurologic, and seizure-control monitoring.